• HRC2022
  • 9 - 11 Oct 2022
AF Association Symposia 1 - AF detection in different contexts- how do we get it right for the local population
Arrhythmia Alliance and Venice Arrhythmias Joint Session
Idiopathic Ventricular Fibrillation
AF Association Symposia 2 - Correct - Drugs vs Ablation session
Hugh Calkins Named Lecture
British Society for Heart Failure - Clash of the Titans - Heart Failure and AF

AF Association Symposia 1 - AF detection in different contexts- how do we get it right for the local population -

Chair: Prof Ben Freedman, Prof Jeroen Hendriks Sydney, AU, Maastricht, NL; Adelaide, AU
What works for whom in AF screening- a realist review Dr Coral Hanson Edinburgh, UK
AF screening in indigenous populations Mr Suud Nahdi Sydney, AU
Rural screening for AF Dr Jessica Orchard Sydney, AU
Pharmacy based AF screening Prof Filipa Alves da Costa Lisbon, PT
AF Detection in Vaccine Clinics Dr Nithya Nanda, Mrs Trudie Lobban Slough, UK, Winchester, UK
Discussion

Arrhythmia Alliance and Venice Arrhythmias Joint Session -

Chair: Prof Carlos Morillo Calgary, CA
Lifestyle and risk factors modification: implementation and results Dr Antonio Rossillo Vicenza, IT
Rhythm vs. rate control: is it time to change strategy? Dr Sakis Themistoclakis Venice-Mestre, IT
New technologies for AF ablation: impact on clinical outcomes Dr Andrea Natale Austin, US
Cardiac neuro ablation/modulation of AF: where are we and where are we going? Prof Tolga Aksu Istanbul, TR
LAA closure: first choice or last chance? Prof Tim Betts Oxford, UK

Idiopathic Ventricular Fibrillation -

Chair: Prof Bernard Belhassen, Prof Pier Lambiase Jerusalem, IL, London, UK
Genetic Testing in idiopathic VF Dr Greg Mellor Cambridge, UK
Short-coupled VF idiopathic ventricular fibrillation: Diagnosis and management Prof Bernard Belhassen Jerusalem, IL
How common is idiopathic VF? Prof Giulio Conte Lugano, CH
How to diagnose idiopathic VF Prof Andrew Krahn Vancouver, CA

AF Association Symposia 2 - Correct - Drugs vs Ablation session -

Chair: Prof Dhiraj Gupta, Prof Sanjiv Narayan Liverpool, UK, Palo Alto, US
Do the outcomes of early rhythm control with catheter ablation extend to patients with persistent AF too? Prof Dhiraj Gupta Liverpool, UK
The impact of anti-arrhythmic drugs on Atrial fibrillation burden Prof Paulus Kirchhof Hamburg, DE
The role of omega-3 fatty acids in atrial fibrillation management Dr Christine Albert Los Angeles, US
Machine Learning to Guide Ablation and Drug Therapy for Atrial Fibrillation Prof Sanjiv Narayan Palo Alto, US
What does Surgical Therapy for Atrial Fibrillation add to Catheter Ablation? Dr David DeLurgio Atlanta, US
Future Trials to Advance Ablation Therapy for Atrial Fibrillation Dr Atul Verma Toronto, CA

Hugh Calkins Named Lecture -

Catheter Ablation for AF - The Past, Present and Future Prof Pierre Jais Bordeaux, FR

British Society for Heart Failure - Clash of the Titans - Heart Failure and AF -

Chair: Professor John McMurray Glasgow, UK
HF Patient Perspective Laurence Humphrey Davies
AF Patient Perspective Di Hallet
Managing Patients with AF - Guideline recommendations/ pathways Dr Rosita Zakeri London, UK
Devices - when and who? Professor Roy Gardner Glasgow, UK
Monitoring - practical tips on using a digital app or wearable within an AF service Prof Derek Connelly Glasgow, UK

Sign up to receive the latest updates